
Kabra Drugs Share Price
₹10.56 0.00 (0.00%)
23 Feb, 2025 04:27
Start SIP in
KABRADG
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 4.97%
- Over 3 Month + 10.11%
- Over 6 Month + 21.24%
- Over 1 Year + 54.16%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
Current Price
₹10.56
0
(0%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹9.71
- 50 Day
- ₹8.55
- 100 Day
- ₹7.30
- 200 Day
- ₹6.07
Resistance and Support
10.56
- R3 10.56
- R2 10.56
- R1 10.56
- S1 10.56
- S2 10.56
- S3 10.56
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-11-04 | Others | |
2024-08-14 | Quarterly Results | |
2024-07-12 | Others | Inter alia, 1. To consider and change the registered office of the Company within the local limits of city where the registered office of the company is presently situated; |
Kabra Drugs F&O
About Kabra Drugs
- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Kabra Drugs FAQs
Kabra Drugs share price is ₹10 As on 23 February, 2025 | 04:13
The Market Cap of Kabra Drugs is ₹10.6 Cr As on 23 February, 2025 | 04:13
The P/E ratio of Kabra Drugs is -5.8 As on 23 February, 2025 | 04:13
The PB ratio of Kabra Drugs is 2.5 As on 23 February, 2025 | 04:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.